ARTICLE | Management Tracks
J&J’s Burton named Moderna CMO; plus Editas, Athira, Yumanity and more
June 14, 2021 9:46 PM UTC
Paul Burton will become CMO at Moderna Inc. (NASDAQ:MRNA) on July 6, succeeding Tal Zaks. Burton is a 16-year veteran of Johnson & Johnson (NYSE:JNJ), most recently serving as chief global medical affairs officer of its Janssen Pharmaceuticals unit.
Gene company Editas Medicine Inc. (NASDAQ:EDIT) named Chi Li SVP and chief regulatory officer. Li was chief regulatory officer at Celularity Inc. ...